Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis: 1-year results from the all-comers NOTION randomized clinical …

HGH Thyregod, DA Steinbrüchel, N Ihlemann… - Journal of the American …, 2015 - jacc.org
Background: Transcatheter aortic valve replacement (TAVR) is an option in certain high-risk
surgical patients with severe aortic valve stenosis. It is unknown whether TAVR can be …

Two-year outcomes in patients with severe aortic valve stenosis randomized to transcatheter versus surgical aortic valve replacement: the all-comers nordic aortic …

L Søndergaard, DA Steinbrüchel… - Circulation …, 2016 - Am Heart Assoc
Background—The Nordic Aortic Valve Intervention (NOTION) trial was the first to randomize
all-comers with severe native aortic valve stenosis to either transcatheter aortic valve …

Transcatheter aortic valve replacement in low-risk patients with symptomatic severe aortic stenosis

R Waksman, T Rogers, R Torguson, P Gordon… - Journal of the American …, 2018 - jacc.org
Background: Transcatheter aortic valve replacement (TAVR) is now the standard of care for
patients with symptomatic severe aortic stenosis who are extreme, high, or intermediate risk …

Cost-effectiveness of transcatheter aortic valve replacement compared with surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results of …

MR Reynolds, EA Magnuson, Y Lei, K Wang… - Journal of the American …, 2012 - jacc.org
Objectives: The aim of this study was to evaluate the cost-effectiveness of transcatheter
aortic valve replacement (TAVR) compared with surgical aortic valve replacement (AVR) for …

[HTML][HTML] Transcatheter aortic valve replacement in low risk patients: a review of PARTNER 3 and Evolut low risk trials

J Braghiroli, K Kapoor, TP Thielhelm… - Cardiovascular …, 2020 - ncbi.nlm.nih.gov
Transcatheter aortic valve replacement (TAVR) has become a mainstay in treatment for
patients with severe aortic stenosis who are considered high-risk surgical candidates. The …

Outcomes of transcatheter and surgical aortic valve replacement in high-risk patients with aortic stenosis and left ventricular dysfunction: results from the Placement of …

S Elmariah, IF Palacios, T McAndrew… - Circulation …, 2013 - Am Heart Assoc
Background—The Placement of Aortic Transcatheter Valves (PARTNER) trial demonstrated
similar survival after transcatheter and surgical aortic valve replacement (TAVR and SAVR …

Eight-year outcomes for patients with aortic valve stenosis at low surgical risk randomized to transcatheter vs. surgical aortic valve replacement

TH Jørgensen, HGH Thyregod, N Ihlemann… - European heart …, 2021 - academic.oup.com
Aims The aims of the study were to compare clinical outcomes and valve durability after 8
years of follow-up in patients with symptomatic severe aortic valve stenosis at low surgical …

Five-year outcomes of transcatheter or surgical aortic-valve replacement

RR Makkar, VH Thourani, MJ Mack… - … England Journal of …, 2020 - Mass Medical Soc
Background There are scant data on long-term clinical outcomes and bioprosthetic-valve
function after transcatheter aortic-valve replacement (TAVR) as compared with surgical …

5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a …

MJ Mack, MB Leon, CR Smith, DC Miller, JW Moses… - The Lancet, 2015 - thelancet.com
Summary Background The Placement of Aortic Transcatheter Valves (PARTNER) trial
showed that mortality at 1 year, 2 years, and 3 years is much the same with transcatheter …

Transcatheter versus surgical aortic valve replacement: propensity-matched comparison

JM Brennan, L Thomas, DJ Cohen, D Shahian… - Journal of the American …, 2017 - jacc.org
Background: Randomized trials support the use of transcatheter aortic valve replacement
(TAVR) for the treatment of aortic stenosis in high-and intermediate-risk patients, but the …